Genome site editing detection method based on RNA sensing system

Through the genome locus editing detection method based on RNA sensing system, the gene editing report system is used to identify and classify genome editing events, and the problem of detecting multi-site editing in the existing technology is solved, real-time and accurate genome editing monitoring is achieved , reducing economic and time costs.

CN118931960APending Publication Date: 2024-11-12GERMPLASM INNOVATION GRAND SCIENCE CENTER OF WESTERN CHINA (CHONGQING) SCIENCE CITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410975551.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing genome editing techniques are difficult to detect multi-site editing events accurately and in real time, and traditional methods are destructive to cells and tissues, time-consuming and labor-intensive. The detection strategy is often to sequence each target site, resulting in false positive results. and high economic costs.

Method used

Using genomic locus editing detection method based on RNA sensing system, a gene editing and reporting system containing internal reference genes, self-splicing peptides and reporter genes is introduced, and ADAR adenosine deaminase is used to identify UAG codons in target RNA to inhibit reporter genes. Translation of genomic loci visualization and classification.

Benefits of technology

Achieve non-invasive and real-time monitoring of genome multi-site editing in living cells, avoiding exogenous DNA integration, simplifying the detection process, reducing costs, improving detection accuracy and efficiency, and being able to detect single and multiple sites at the same time mutation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931960A_ABST
    Figure CN118931960A_ABST
Patent Text Reader

Abstract

The invention relates to a genome site editing detection method based on an RNA (Ribonucleic Acid) sensing system, which is characterized in that the detection of mRNA (Messenger Ribonucleic Acid) of a target gene and the translation of a reporter gene are combined by utilizing ADAR (Adenosine Deaminase)-mediated RNA editing, and viable cells edited by the target gene are visualized and sorted through the expression level change of the reporter gene. The genome editing report system disclosed by the invention can be used for directly detecting, visualizing and sorting genome editing living cells. The system plays a role in different organisms in a simple, universal and generalizable manner, can effectively feed back the genome editing condition in real time, can lay a solid foundation for large-scale application of a genome editing technology and development of a novel gene editing tool, and has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of genetic engineering, and in particular relates to a genome site editing detection method based on an RNA sensing system. Background Art

[0002] The birth of gene editing technology is a milestone in the field of life science research. Reverse genetics research methods based on genome editing, as well as genome resequencing and whole genome editing technologies have brought gene function research into the post-genomic era. On this basis, new genome editing tools, such as single-base editing and lead editing, have emerged in an endless stream, enabling people to engineer and edit target genes in a more precise manner. Genome editing technology has the advantages of programmability, simplicity, no need for exogenous DNA integration, and traceless repair. It also has great application prospects in agricultural breeding, environmental control, and genetic disease treatment.

[0003] However, despite the great achievements and widespread applications of genome editing, accurate detection of mutations caused by genome editing remains a challenge because most genome editing does not involve the combination of any selection markers. In the process of gene function research, multiple genes are often edited simultaneously to identify their regulatory networks; or multiple sites of a single gene are edited to identify the functional domains of its protein products. This urgently requires a reporting system that can visualize and monitor multi-site editing events in real time.

[0004] At present, the detection of genome-edited cells mostly adopts the harvest-sort-sequencing method, in which the transfected cells are first sorted by time-consuming and laborious processes such as gradient dilution or flow cytometry, and then genotyped by extracting genomic DNA of some cells in vitro, PCR amplification of target site sequences and Sanger sequencing technology; or by methods including enzyme digestion, high-resolution melting analysis and NGS sequencing; and recently developed methods such as CRISPR ribonucleoprotein digestion of PCR products, oligonucleotide interference PCR and digital PCR. The detection method for multi-site editing of the genome mostly adopts the sampling and sequencing method, and the detection strategy is often to sequence each target site separately. This detection method is destructive and invasive to cultured cells or individual tissues, and the materials lose their other use value after one-time sequencing. In addition, sequencing the target sites separately requires strict screening and purification of a large amount of transgenic materials, which undoubtedly consumes a lot of time and economic costs. Therefore, establishing a non-invasive, real-time monitoring method for multi-site editing events in the genome of living cells is conducive to overcoming the limitations of existing methods, saving labor costs, improving the development and application level of genome editing technology, and helping to study the signaling pathways and regulatory networks of functional genes faster and better.

[0005] Target DNA mutations are difficult to monitor in real time, mainly because they are very small, usually one or two single molecules (alleles) in the cell nucleus, and cannot be artificially amplified like PCR. Multi-site editing events are difficult to detect because their probability of occurrence is lower than single-site editing. To detect multi-site editing, it is necessary to strictly select a large number of cells or individuals with different mutation forms to avoid false positive detection results caused by cells or chimeric individuals with different single target site mutations.

[0006] RNA is a central and universal mediator of genetic information, accurately delivering target DNA sequence information from the nucleus to different cellular compartments with detectable amplified signals. Therefore, we proposed that DNA targets for genome multisite editing might be detected in living cells through their transcribed form, RNA. Recently, ADAR adenosine deaminases have been developed to sense target RNA based on simple Watson-Crick base pairing rules. In this technology, the target RNA information is converted into a downstream signal by translationally reading an in-frame UAG stop codon upstream of a reporter or effector protein, which is edited to UIG and recognized as UGG by the translation machinery in the presence of the target RNA. However, whether this technology can distinguish transcripts of genome multisite editing target RNA from wild-type RNA remains unknown. Summary of the invention

[0007] The present invention provides a method for detecting genome site editing based on an RNA sensing system, which does not require any exogenous DNA to be integrated into the host genome. Without affecting the normal growth of living cells, any cells containing genome single-site or multi-site editing of transcriptional genes in living cells can be visualized and classified.

[0008] The present invention provides a method for detecting genome site editing based on an RNA sensing system, wherein one or more different gene editing reporter systems are introduced into a host for expression, and the basic structure of the gene editing reporter system is shown in Formula 1:

[0009] Formula 1 5'XA-sesRNA-BY 3'

[0010] Wherein, X is an internal reference gene, A is a self-splicing peptide 1, sesRNA is an RNA sequence containing a UAG codon for sensing the presence of trgRNA, wherein the trgRNA is encoded by a wild-type target gene, B is a self-splicing peptide 2, and Y is a reporter gene;

[0011] Among them, the translation of the internal reference gene is not affected by RNA sensing, and the self-splicing peptide is used to release the internal reference gene and the reporter gene. When the target site on the wild-type target gene is not edited, trgRNA can match with sesRNA normally, recruit ADAR to change the UAG codon in sesRNA to UIG codon, so that the reporter gene can be translated normally. When the target site on the wild-type target gene is edited, trgRNA and sesRNA match abnormally, affecting the recruitment of ADAR and inhibiting the translation of the reporter gene. The editing status of the genomic site is detected by detecting the translation of the reporter gene.

[0012] Furthermore, the number of the gene editing reporter systems is determined according to the number of targets, and the sesRNA sequences, internal reference genes and reporter genes of different gene editing reporter systems are all different, specifically: the internal reference gene is any fluorescent protein within the detection range of flow cytometry; the self-splicing peptides include T2A, P2A, E2A, and F2A; the reporter gene is any fluorescent protein within the detection range of FACS whose excitation wavelength and emission wavelength are both the same as the internal reference fluorescence without overflow; the sesRNA is a readable nucleic acid sequence that is reverse complementary to the target mRNA, and the sequence length is between 3n→3m, n=24, m=116, and sesRNA that is too long or too short will reduce the RNA sensing efficiency.

[0013] Furthermore, one or more plasmid vectors containing a gene editing reporter system are introduced into a host cell for expression, and the editing of the target gene in the host cell is detected by detecting the translation of the reporter gene.

[0014] Furthermore, when performing single-site editing detection, transfection-positive cells are enriched by flow cytometry based on the internal reference fluorescence of the vector, and then the cells are sorted based on the fluorescence of the reporter gene. If the target gene mutates, the expression level of trgRNA will decrease, thereby causing the expression level of the reporter gene to decrease, which is manifested as a decrease in cell fluorescence intensity. Therefore, cells with fluorescence intensity lower than the control level are target gene-edited cells, and cells with no significant difference from the control level are normal cells.

[0015] Furthermore, when performing multi-site editing detection, transfection-positive cells are enriched by flow cytometry based on the internal reference fluorescence of the vector, and then the cells are sorted based on the fluorescence of the reporter gene. If multiple target sites are edited, the expression level of trgRNA will decrease, thereby causing the expression level of the reporter gene to decrease, which is manifested as a decrease in cell fluorescence intensity. Therefore, cells with fluorescence intensity significantly lower than the control level are cells in which multiple target sites are edited, and cells with no significant difference from the control level are normal cells or single-site edited cells.

[0016] Furthermore, the multi-site editing includes single-gene two-site editing, double-gene two-site editing, three-gene three-site editing, and four-gene four-site editing.

[0017] Furthermore, the method is used to detect host target gene editing caused by CRISPR / Cas, ZFNs, and TALENs technologies.

[0018] Furthermore, the host cells include HEK293T cells, and the target genes include HER2, ActB, TP53, and PCNA.

[0019] Furthermore, the method is for non-disease diagnosis or treatment purposes.

[0020] The present invention also provides the application of any of the above methods in genomic site editing detection.

[0021] Furthermore, the application is for non-disease diagnosis or treatment purposes.

[0022] Beneficial effects:

[0023] The genomic site editing detection method based on the RNA sensing system of the present invention is a non-invasive method that does not require the introduction of any exogenous marker genes into the genome, and the transient expression of the reporter gene does not affect the state of the living cells being tested.

[0024] The method can directly and accurately detect mutations in target DNA in living cells, while previous methods could only provide indirect evidence such as sequencing of neighboring cells, or indicate through transfection selection markers and co-editing marker genes.

[0025] The described method can combine the visualization and sorting of positive genome-edited cells in one step by simple fluorescence microscopy and flow cytometry.

[0026] The mutant line obtained by the method is a pure, full mutant line, which can be used to screen polyploid cells and other situations where it is currently difficult to obtain a full knockout line.

[0027] The method can simultaneously detect and screen mutations at a single site, multiple sites, and multiple genes, laying the foundation for high-throughput gene editing experiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0029] Figure 1The working principle of the RNA sensing-based gene editing reporter system (editREADAR).

[0030] Figure 2 The editing status of the termination codon TAG in the sesRNA of the positive cells detected by Sanger sequencing in Example 2. neg is the sequencing result of the RT-PCR product of the light-free cell group, and pos is the sequencing result of the RT-PCR product of the light-emitting cell group. The sequencing primer is located at the 5′ end of T2A.

[0031] Figure 3 The results of the detection of the effect of the RNA-sensing gene editing reporter system on the life activities of 293T cells in Example 3. Figure A shows the transcriptome analysis of the reporter system on the gene expression level of 293T cells; Figure B shows the cell activity detection of labeled cells and control cells. Figure C shows the expression level of the target gene in labeled cells and control cells.

[0032] Figure 4 This is the detection of target gene knockout by the RNA-sensing gene editing reporter system in Example 4. Figure A shows the strategy of using the reporter system to screen target gene knockout cells; Figure B shows the vector structure of the knockout system and the reporter system; Figure C shows the fluorescence of 293T cells co-transfected with sesRNA and gRNA detected by flow cytometry; Figure D shows the percentage statistics of mutated target sequences and unmutated target sequences in fluorescence-positive cells and negative cells; Figure E shows the statistics of target sequence mutation forms.

[0033] Figure 5 The genomic site editing reporter system monitoring of the single gene dual-site editing in Example 5. Figure A shows the structure of sesRNAs with different internal reference fluorescence; Figure B shows the construction of dual gRNA vectors; Figure C shows the fluorescence of 293T cells co-transfected with sesRNAs and gRNAs detected by flow cytometry; Figure D shows the statistics of the proportion of dual-site mutated target sequences and unmutated target sequences in fluorescence-positive cells and negative cells; Figure E shows the statistics of target sequence mutation forms.

[0034] Figure 6 The genomic site editing reporter system monitoring of dual gene editing in Example 6. Figure A shows the fluorescence of 293T cells co-transfected with sesRNAs and gRNAs detected by flow cytometry; Figure B shows the percentage statistics of dual gene mutation target sequences and non-mutated target sequences in fluorescence positive cells and negative cells; Figure C shows the statistics of target gene mutation forms. DETAILED DESCRIPTION

[0035] The following examples are only used to more clearly illustrate the technical scheme of the present invention, and are therefore only used as examples, and cannot limit the scope of protection of the present invention. It should be noted that, unless otherwise stated, the technical terms or scientific terms used in this application should be the usual meanings understood by those skilled in the art to which the present invention belongs. Unless otherwise stated, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art. Unless otherwise stated, the reagents and materials used in the following examples are commercially available.

[0036] Example 1: Construction of editREADAR system

[0037] The working principle of the RNA-sensing gene editing reporting system (editREADAR) of the present invention is as follows Figure 1 As shown, it mainly includes editREADER mRNA, and its basic structure is shown in Formula 1:

[0038] Formula 1 5'XA-sesRNA-BY 3'

[0039] Wherein, X is an internal reference gene Marker (e.g., dsRed), A is a self-splicing peptide 1 (e.g., 2A peptide), sesRNA is an RNA sequence containing a UAG codon for sensing the presence of trgRNA, wherein the trgRNA is encoded by a wild-type target gene, B is a self-splicing peptide 2 (e.g., 2A peptide), and Y is a reporter gene Reporter (e.g., EGFP);

[0040] Among them, the translation of the reference gene is not affected by RNA induction, and the self-splicing peptide is used to release the reference gene and the reporter gene. When the target site is not edited, the target gene can encode trgRNA normally, and match and bind with sesRNA normally to form double-stranded RNA, and then recruit ADAR to change the stop codon UAG in sesRNA to UIG codon, so that the reporter gene can be translated normally. Therefore, the reference gene and the reporter gene in the wild-type cell can be translated normally, and two fluorescent proteins can be obtained. When the target site is edited, the target gene cannot encode trgRNA normally, and trgRNA and sesRNA match abnormally and cannot form double-stranded RNA, which affects the recruitment of ADAR, causing editREADER mRNA to terminate translation at the stop codon UAG, inhibiting the translation of the reporter gene. Therefore, the reporter gene in the cell where the genome is edited cannot be translated normally, and only one fluorescent protein can be obtained. Therefore, the editing of the genome site can be detected by detecting the translation of the reporter gene.

[0041] Now, taking HER2, PCNA, TP53, and ActB genes as examples, the effectiveness of the detection method of the present invention is verified, as follows:

[0042] The mRNA sequences of target genes HER2, PCNA, TP53, and ActB were downloaded from the NCBI database. RADARS GuideDesign Tool (https: / / www.radars.bio / ) was used to design sesRNA; CCTop-CRISPR / Cas9 targetonline predictor (https: / / cctop.cos.uni-heidelberg.de:8043) was used to design sgRNA. In the experimental process, the present invention found that after the editREADAR system and the CRISPR / Cas9 system were co-transfected into cells, there was a certain mutual influence between the systems, which in turn affected the editing efficiency of sgRNA and the detection efficiency of sesRNA. Therefore, the present invention avoided the mutual influence between the two systems by optimizing the sequences of sesRNA and sgRNA, and effectively improved the detection efficiency while ensuring the editing efficiency. The specific sequences are shown in Table 1 and the sequence table SEQ ID NO: 1-8.

[0043] Table 1

[0044]

[0045]

[0046] Build as Figure 4 The vector shown in B, wherein sesRNA is composed of positive control (ATG), negative control (TAA) and sesRNA of four target genes (HER2, PCNA, TP53, ActB); gRNA includes a leader sequence targeting four target genes (HER2, PCNA, TP53, ActB). The target fragment was PCR amplified using PrimerSTAR high-fidelity polymerase produced by TaKaRa Bio, and the target fragment was recovered using Gel Extraction Kit produced by OMEGA. The target fragment was digested and ligated with restriction endonucleases and T4 DNA ligase produced by NEB, and the transformation experiment was performed using Trans-T1 competent cells produced by Transgen. The endotoxin-free plasmid was extracted using Qiagen's Spin Mini prep Kit.

[0047] The CRISPR / Cas9 system is connected to GFP, the internal reference gene in the gene editing reporter system is RFP, and the reporter gene is BFP. The sesRNA and sgRNA of the four genes TP53, HER2, PCNA and ActB were co-transfected into 293T cells, and the fluorescence and intensity of the cells were detected. Those that did not fluoresce were not successfully introduced, those that only emitted red light were not successfully introduced into the CRISPR / Cas9 system, and those that only emitted green light were not successfully introduced into the gene editing reporter system; and cells that were introduced into both systems at the same time, if there were red, green and blue fluorescence, it was wild type, indicating that the target gene was not edited and no mutation occurred; if there were only red and green fluorescence but no blue fluorescence, it was mutant type, that is, the target gene was successfully edited and mutated.

[0048] Example 2: Using 293T cells to test the effectiveness of the editREADAR system

[0049] The sesRNA and sgRNA of TP53, HER2, PCNA and ActB were co-transfected into 293T cells. After 72 h of culture, the fluorescence intensity of 293T cells was detected by flow cytometry. Figure 4 C, where the left side of the red dotted line is a cell without blue light, indicating that the reporter system is not activated, that is, the target gene is mutated. In contrast, the cells to the right of the dotted line are those cells in which the target gene has not mutated. The results show that different samples contain different proportions of red and green dual light. We calculated the efficiency of different sesRNAs based on the ratio of positive cells (pos) to total cells (neg+pos). Figure 4 C The results show that the efficiency of the four sesRNAs we designed is significantly higher than that of the negative control (NC: 1%). In order to detect whether the stop codon UAG in the sesRNA is edited to UGG (UIG), we extracted total RNA from 293T cells and used RT-PCR to detect, as shown in Figure 2 Figure 2 As shown, neg is the sequencing result of the RT-PCR product of the light-free cell group, and pos is the sequencing result of the RT-PCR product of the light-emitting cell group. The sequencing primer is located at the 5′ end of T2A. The results show that compared with the negative cells (neg), the UAG in the sesRNA of the positive cells (pos) is edited to UGG (UIG). Flow cytometry, cell transfection operation is as follows:

[0050] Flow cytometry (FACS): The cells in different treatment groups were washed twice with PBS, and then 200-500 μL of sterile PBS was used to blow off the cells and filter through a 300-mesh cell sieve to separate them into single cell suspensions. The samples in different treatment groups were machine-tested in turn to analyze the proportion of different fluorescent positive cells in each group.

[0051] Transfection of 293T cells: Cells in good condition with a density of 80%-90% were spread on a 12-well cell culture plate with a density of about 70%. The cells in the 12-well plate were cultured overnight until the density reached 80-90%. The plasmid was 1μg and the transfection reagent was 3μL per well during preparation. 200μL DMEM medium (Gibco, New York, USA) was added to a 1.5mL sterile centrifuge tube, and 3μL transfection reagent (Roche's X-treme GENE HP DNA transfection reagent; Roche, Basel, Switzerland) was added, mixed and allowed to stand for 5min. 200μL DMEM medium was added to a 1.5mL sterile centrifuge tube, and 1μg of plasmid was added and mixed. The plasmid mixture was added to the transfection reagent mixture, mixed and allowed to stand for 20min. The entire mixture was added to the culture medium and mixed well. After culturing at 27°C for 6-8h, the culture medium was completely replaced and continued to be cultured. Subsequent tests were performed as needed.

[0052] Example 3: Examining the effects of the editREADAR system on cell life activities

[0053] The activity of transfected cells and control cells was measured using the CCK8 cell activity assay kit. Figure 3 B Results show that there is no significant difference in the viability of cells transfected with sesRNA of different genes compared with control cells, indicating that editREADAR has no significant effect on the biological activity of 293 cells. Considering that sesRNA recruits mRNA of target genes, the expression levels of target genes in transfected cells and control cells were detected. Figure 3 C The results showed that there was no significant change in the expression level of the target gene before and after sesRNA transfection, indicating that editREADAR had no significant effect on the expression of the target gene. The transcriptomes of transfected cells and control cells were sequenced. Figure 3 A results show that there is a significant correlation between the gene transcription levels of sesRNA cells and control cells, that is, there is no significant difference in gene expression between the two groups, indicating that editREADAR has no significant effect on the gene expression of 293 cells. The qRT-PCR operation is as follows:

[0054] qRT-PCR: Cellular RNA was extracted using the HiPure Universal RNA-mini Kit produced by MAGEN. RNA was reverse transcribed using the One-Step gDNA Removal and cDNA Synthesis SuperMix produced by Transgen. qRT-PCR was performed using the Top Green qPCR SuperMix (+Dye I) produced by Transgen.

[0055] Example 4: Detection of Cas9-induced single-site targeted mutations in living cells using editREADAR

[0056] After sesRNA and sgRNA of TP53, HER2, PCNA and ActB were co-transfected into 293T cells, green and red fluorescent double-positive cells were sorted by flow cytometry, and the reporter gene was BFP. Mutation of the target gene will lead to a decrease in the expression level of trgRNA, which will lead to a decrease or even no expression level of the reporter gene BFP, which is manifested as a decrease or no blue fluorescence intensity of the cells. Therefore, cells with blue fluorescence intensity lower than the control level are target gene mutation cells, and cells with no significant difference from the control level are normal cells.

[0057] The genomic DNA of the two groups of cells was extracted and the target sequence was amplified by PCR. The PCR products were sequenced by Sanger sequencing and NGS sequencing, respectively. Figure 4 D and 4E respectively counted the proportion of mutated sequences to non-mutated sequences and the distribution of mutation forms of mutated sequences. Figure 4 D represents the statistical proportion of mutated target sequences and non-mutated target sequences in fluorescence-positive cells and negative cells, where gray represents the proportion of non-mutated sequences and orange represents the proportion of mutated sequences. Figure 4 Figure E shows the statistics of target sequence mutation forms, where orange represents the mutation sequence of fluorescence-positive cells and gray represents the mutation sequence of negative cells. Since small fragment deletions account for the vast majority of mutation forms, only the frequency of base deletions at different sites upstream and downstream of the target site seed sequence is counted here.

[0058] The results showed that the editREADAR system had a significant enrichment effect on mutant sequences, that is, the editREADAR system was able to detect single-site targeted mutations induced by Cas9 in living cells.

[0059] Example 5: Monitoring single gene dual-site editing using an RNA-sensing based genomic site editing reporter system

[0060] Build Figure 5 The dual gRNA vector targeting two different sites of a single gene shown in B and Figure 5 The sesRNAs targeting these two different internal reference fluorescent sites shown in A are used to screen cells with simultaneous mutations in two target sites of a single gene. RFP and YFP are internal reference fluorescent genes, BFP is a reporter fluorescent gene, sesRNA1 is a sensing RNA targeting the first target site, and sesRNA2 is a sensing RNA targeting the second target site. The construction of the dual gRNA vector requires the PX330 vector linearized with BbsI as the construction backbone, and two independent sgRNA expression frames are formed by PCR amplification and double-fragment Gibson assembly.

[0061] Two sesRNA vectors and one double gRNA vector were co-transfected into 293T cells, and the fluorescence and intensity of the cells were detected by flow cytometry after 72 hours. Among them, cells with positive red, yellow and green fluorescence were transfected positively. In transfected positive cells, the translation of the reporter gene (blue fluorescent protein) can only be terminated when both target sites are mutated, but not when a single target site is mutated or not mutated. Therefore, in transfected positive cells, the intensity of blue light indicates that the two target sites of the gene have mutated, and cells with mutations in both target sites of the target gene are screened by screening cells with blue light intensity lower than the negative control level.

[0062] In this example, HER2, PCNA, TP53, and ActB genes were used as examples to construct dual gRNA vectors targeting two different sites of a single gene and corresponding sesRNA reporting systems. To avoid the interaction between the editREADAR system and CRISPR / Cas9, the sequences of the two sesRNAs and two sgRNAs were optimized to effectively improve the detection efficiency while ensuring the editing efficiency. The sequences are shown in Table 2 and the sequence table SEQ ID NO: 1-16:

[0063] Table 2

[0064]

[0065]

[0066] Flow cytometry results Figure 5 As shown in C, the cells on the left side of the red dotted line are cells without blue light, indicating that the reporter system is not activated, that is, both target sites on the genome are mutated. In contrast, the cells on the right side of the dotted line are cells with a single target site mutation or no target site mutation. The genomic DNA of the two groups of cells was extracted, and the target sequence was amplified by PCR. The PCR products were sequenced by Sanger and NGS, respectively. Figure 5 D and 5E respectively counted the proportion of mutated sequences to non-mutated sequences and the distribution of mutation forms of mutated sequences. Figure 5 D represents the percentage of double-site mutated target sequences and non-mutated target sequences in fluorescence-positive cells and negative cells. Gray represents the percentage of non-mutated sequences, and orange represents the percentage of double-site mutated sequences. Figure 5 E is the statistics of target sequence mutation forms, orange represents the mutation sequence of fluorescence-positive cells, and blue represents the mutation sequence of negative cells. Since small fragment deletions account for the vast majority of mutation forms, only the frequency of base deletions at different sites upstream and downstream of the target site seed sequence is counted here.

[0067] The results showed that the reporter system produced a significant enrichment effect on the single gene double site mutation sequence, that is, the genomic site editing reporter system can detect CRISPR / cas9-induced single gene double site mutations in living cells. Flow cytometry and cell transfection operations were the same as in Example 2.

[0068] Example 6: Monitoring dual-gene dual-site editing using an RNA-sensing based genomic site editing reporter system

[0069] Dual gRNA vectors targeting two different genes and sesRNAs targeting these two different sites with different fluorescence parameters were constructed to screen cells with simultaneous mutations in the two target genes. Two sesRNA vectors and one dual gRNA vector were transfected into 293T cells and detected by flow cytometry after 72 hours. According to our design, cells with positive red, yellow, and green fluorescence were transfected as positive. In transfected positive cells, the translation of the reporter gene (blue fluorescent protein) was terminated only when both target genes were mutated, but not when a single target gene was mutated or not mutated. Therefore, in transfected positive cells, the intensity of blue light indicates that the two target sites of the gene have mutated. If the blue light intensity is lower than the negative control level, it indicates that both target genes have mutated.

[0070] In this example, HER2, PCNA, TP53, and ActB genes are taken as examples, and dual gRNA vectors targeting different sites of two different genes and corresponding sesRNA reporter systems are constructed, including: TP53 and PCNA mutations at the same time, HER2 and ActB mutations at the same time, PCNA and HER2 mutations at the same time, ActB and TP53 mutations at the same time, and the sequences are shown in Table 3:

[0071] Table 3

[0072]

[0073]

[0074]

[0075] Flow cytometry results Figure 6 As shown in A, the cells on the left side of the red dotted line are cells without blue light, indicating that the reporter system is not activated, that is, both target genes are mutated. In contrast, the cells on the right side of the dotted line are cells with single gene mutations or no target genes are mutated. Genomic DNA of the two groups of cells was extracted and the target sequence was amplified by PCR. The PCR products were sequenced by Sanger and NGS, respectively. Figure 6 B and 6C respectively counted the proportion of mutated sequences to non-mutated sequences and the distribution of mutation forms of mutated sequences. Figure 6B represents the statistical proportion of double-gene mutation target sequences and non-mutation target sequences in fluorescence-positive cells and negative cells. Blue represents the proportion of non-mutation sequences, and orange represents the proportion of double-site mutation sequences. Figure 6 C is the statistics of target gene mutation forms. Orange represents the mutation sequence of fluorescence-positive cells, and blue represents the mutation sequence of negative cells. Since small fragment deletions account for the vast majority of mutation forms, only the base deletion frequencies at different sites upstream and downstream of the target site seed sequence are counted here.

[0076] The results showed that the reporter system had a significant enrichment effect on double gene mutation sequences, that is, the genomic site editing reporter system was able to detect double gene mutations induced by CRISPR / cas9 in living cells.

[0077] The above specific embodiments describe the implementation of the present invention in detail, but the present invention is not limited to the specific details in the above embodiments. Within the scope of the claims and technical concept of the present invention, the technical solution of the present invention can be modified and changed in many simple ways, and these simple modifications all belong to the protection scope of the present invention.

Claims

1. A method for detecting genome site editing based on an RNA sensing system, characterized in that: One or more different gene editing reporter systems are introduced into the host for expression. The basic structure of the gene editing reporter system is shown in Formula 1: Formula 1 5'XA-sesRNA-BY 3' Wherein, X is an internal reference gene, A is a self-splicing peptide 1, sesRNA is an RNA sequence containing a UAG codon for sensing the presence of trgRNA, wherein the trgRNA is encoded by a wild-type target gene, B is a self-splicing peptide 2, and Y is a reporter gene; Among them, the translation of the internal reference gene is not affected by RNA sensing, and the self-splicing peptide is used to release the internal reference gene and the reporter gene. When the target site on the wild-type target gene is not edited, trgRNA can match with sesRNA normally, recruit ADAR to change the UAG codon in sesRNA to UIG codon, so that the reporter gene can be translated normally. When the target site on the wild-type target gene is edited, trgRNA and sesRNA match abnormally, affecting the recruitment of ADAR and inhibiting the translation of the reporter gene. The editing status of the genomic site is detected by detecting the translation of the reporter gene.

2. The method according to claim 1, characterized in that The number of the gene editing reporter systems is determined according to the number of targets, and the sesRNA sequences, internal reference genes and reporter genes of different gene editing reporter systems are all different, specifically: the internal reference gene is any fluorescent protein within the detection range of flow cytometry; the self-splicing peptides include T2A, P2A, E2A, and F2A; the reporter gene is any fluorescent protein within the detection range of FACS whose excitation wavelength and emission wavelength are both the same as the internal reference fluorescence without overflow; sesRNA is a readable nucleic acid sequence that is reverse complementary to trgRNA, and the sequence length is between 3n→3m, n=24, m=116.

3. The method according to any one of claims 1-2, characterized in that: One or more plasmid vectors containing a gene editing reporter system are introduced into host cells for expression, and the editing of the target gene in the host cells is detected by detecting the translation of the reporter gene.

4. The method according to any one of claims 1-2, characterized in that: When performing single-site editing detection, flow cytometry is used to enrich transfection-positive cells based on the internal reference fluorescence of the vector, and then the cells are sorted based on the fluorescence of the reporter gene. If the target gene mutates, the expression level of trgRNA will decrease, thereby causing the expression level of the reporter gene to decrease, which is manifested as a decrease in cell fluorescence intensity. Therefore, cells with fluorescence intensity lower than the control level are target gene-edited cells, and cells with no significant difference from the control level are normal cells.

5. The method according to any one of claims 1-2, characterized in that: When performing multi-site editing detection, flow cytometry is used to enrich transfection-positive cells based on the internal reference fluorescence of the vector, and then the cells are sorted based on the fluorescence of the reporter gene. If multiple target sites are edited, the expression level of trgRNA will decrease, thereby causing the expression level of the reporter gene to decrease, which is manifested as a decrease in cell fluorescence intensity. Therefore, cells with fluorescence intensity significantly lower than the control level are cells in which multiple target sites are edited, and cells with no significant difference from the control level are normal cells or single-site edited cells.

6. According to the method of claim 5, the multi-site editing includes single-gene two-site editing, double-gene two-site editing, three-gene three-site editing, and four-gene four-site editing.

7. The method according to any one of claims 1-2, characterized in that: The method is used to detect host target gene editing caused by CRISPR / Cas, ZFNs, and TALENs technologies.

8. The method according to claim 3, characterized in that The host cells include HEK293T cells, and the target genes include HER2, ActB, TP53, and PCNA.

9. Use of the method according to any one of claims 1 to 8 in detecting genomic site editing.